🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial studies how well ixazomib and rituximab work in treatin...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2019-08-28
Trial ID
NCT04047797
Treatments Being Tested
Follicular lymphoma (FL) and marginal zone lymphoma (MZL) are the most comm...
Status
Unknown
Location
Biotherapeutic Department, Chinese PLA General Hospital
Start Date
2021-12-31
Trial ID
NCT05073250
This study will test the safety and effectiveness of using lower-dose ritux...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2006-08-10
Trial ID
NCT00366418
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as cyclophosphamide, doxorubici...
Status
Completed
Location
Multiple Locations
Start Date
2004-05
Trial ID
NCT00726700
Treatments Being Tested
Pre-clinical data and recently published clinical data suggest a synergisti...
Status
Completed
Location
University of Pennsylvania; Abramson Cancer Center; Lymphoma Program
Start Date
2008-07
Trial ID
NCT00783367
Treatments Being Tested
This is a two-part, non-randomized, open-label Phase I clinical study. The ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07169565
Treatments Being Tested
The goal of this clinical trial is to learn if a new drug that might help p...
Status
Recruiting
Location
Vseobecna fakultni nemocnice v Praze
Start Date
2023-09-07
Trial ID
NCT06047171
Treatments Being Tested
This is a prospective, single-arm, single-center, explorative clinical tria...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2023-05-25
Trial ID
NCT05828147
Treatments Being Tested
This is an open label, Phase 1/2, first-in-human, multiple ascending dose, ...
Status
Recruiting
Location
Valkyrie Clinical Trials
Start Date
2023-10-25
Trial ID
NCT06119685
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
Haematologisch Onkologische Praxis
Start Date
2005-11
Trial ID
NCT00278421
Treatments Being Tested